Wednesday, July 18, 2018 4:12:44 PM
Dr. Ian Zagon is an advisor to IMUN/Cytocom and the article is about very important therapeutic potentials for methionine enkephalin (MENK) for which, as you should know, IMUN possesses use patents. OGF (Opioid Growth Factor) is methionine enkephalin.
This article is food for thought and provides just more indication of lost opportunity for IMUN/Cytocom in progressing with the needed clinical studies for which the companies were established. Note on page 249 of article under Financial & Competing Interests Disclosure. Reminder-TNI Biotech Inc. is now IMUN.
Here is the link: www.ncbi.nlm.nih.gov/pubmed/24397732
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM